Literature DB >> 20440682

Human parainfluenza virus type 3 (HPIV-3): construction and rescue of an infectious, recombinant virus expressing the enhanced green fluorescent protein (EGFP).

Jason P Roth1, Joseph K-K Li, Dale L Barnard.   

Abstract

The ability to rescue an infectious, recombinant RNA virus from a cDNA clone has led to new opportunities for measuring viral replication from a viral expressed reporter gene. In this protocol, the process of inserting the enhanced green fluorescent protein (EGFP) gene into the human parainfluenza virus type 3 (HPIV-3) antigenome and rescuing a recombinant, infectious virus is described. The first step in this process includes the generation of a cDNA clone copied from viral RNA isolated from an HPIV-3 wild-type infection. Next, the EGFP gene is inserted into the viral genome so that it is expressed independently during virus replication. Third, the viral support genes that are responsible for viral replication are cloned into T7 expression plasmids. Finally, an infectious, rHPIV3-EGFP virus is rescued from the cDNA clone with assistance from the viral support genes. Ultimately, cells infected with the rHPIV3-EGFP virus will emit green fluorescence that can be photographed and quantitated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440682      PMCID: PMC2895816          DOI: 10.1002/9780471729259.mc15f01s17

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  25 in total

1.  Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents.

Authors:  M Marschall; M Freitag; S Weiler; G Sorg; T Stamminger
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: comparison with the Wash/47885/57 prototype strain.

Authors:  A Stokes; E L Tierney; B R Murphy; S L Hall
Journal:  Virus Res       Date:  1992-09-01       Impact factor: 3.303

3.  A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA.

Authors:  A T Perrotta; M D Been
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

4.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

5.  Functional characterisation of the genomic and antigenomic promoters of Sendai virus.

Authors:  P Calain; L Roux
Journal:  Virology       Date:  1995-09-10       Impact factor: 3.616

6.  Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Authors:  L S Wyatt; B Moss; S Rozenblatt
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

7.  Structural characterization of virion proteins and genomic RNA of human parainfluenza virus 3.

Authors:  D G Storey; K Dimock; C Y Kang
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

8.  Virus infection of endothelial cells.

Authors:  H M Friedman; E J Macarak; R R MacGregor; J Wolfe; N A Kefalides
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

9.  A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

Authors:  Jason P Roth; Joseph K-K Li; Donald F Smee; John D Morrey; Dale L Barnard
Journal:  Antiviral Res       Date:  2009-02-02       Impact factor: 5.970

10.  Sendai virus vector-mediated gene transfer of glial cell line-derived neurotrophic factor prevents delayed neuronal death after transient global ischemia in gerbils.

Authors:  Masayuki Shirakura; Masayuki Fukumura; Makoto Inoue; Satoshi Fujikawa; Mitsuyo Maeda; Kazuhiko Watabe; Shigeru Kyuwa; Yasuhiro Yoshikawa; Mamoru Hasegawa
Journal:  Exp Anim       Date:  2003-04
View more
  3 in total

1.  Safety of inoculation of bovine parainfluenza virus 3 as potential vaccine vector in pigs.

Authors:  Feng-Xue Wang; Ying Liu; Hong-Wei Zhu; Xing Liu; Yong Yang; Na Sun; Shi-Peng Cheng; Yong-Jun Wen
Journal:  Virusdisease       Date:  2015-04-01

2.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

3.  Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expression.

Authors:  Jason P Roth; Joseph K-K Li; John D Morrey; Dale L Barnard; Almut H Vollmer
Journal:  Virus Genes       Date:  2013-05-18       Impact factor: 2.198

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.